¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

¸íÁöº´¿ø The 3nd MYONGJI INTERNATIONAL LIVER SYMPOSIUM : 2018-09-07

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
¸íÁöº´¿ø The 3nd MYONGJI INTERNATIONAL LIVER SYMPOSIUM : 2018-09-07
±³À°ÀÏÀÚ : 2018-09-07
±³À°Àå¼Ò : ¸íÁöº´¿ø ³óõȦ  
±³À°ÁÖÁ¦ : The 3nd MYONGJI INTERNATIONAL LIVER SYMPOSIUM      
ÁÖÃÖ±â°ü :¸íÁöº´¿ø
´ã´çÀÚ : ÀÌÀåÇö
¿¬¶ôó : 031-810-5024  
À̸ÞÀÏ : jasonuranos@mjh.or.kr      
±³À°Á¾·ù : ³»°ú      
Âü¼®¿¹»óÀοø : 150¸í
Èñ¸ÁÆòÁ¡ : 4Á¡  
Áö¿ª : °æ±âµµ
±³À°½Ã°£ : 4 ½Ã°£ 0ºÐ  
¼¼ºÎ¼ö°­·á : 0¿ø      
ºñ°í       
       
±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 09¿ù 07ÀÏ ¸íÁöº´¿ø ³óõȦ 13:00~13:30 Á¢¼ö ¹× Àλ縻  Prof. Hyo-Suk Lee(Myongji Hospital Goyangsi Korea) 
±³À°½Ã°£ 09¿ù 07ÀÏ ¸íÁöº´¿ø ³óõȦ 13:30~13:45 Changing Epidemiology: Increasing burden of non-B, non-C liver diseases in Korea  Prof. Young-Suk Lim(Asan Medical Center Seoul Korea) 
±³À°½Ã°£ 09¿ù 07ÀÏ ¸íÁöº´¿ø ³óõȦ 13:45~14:00 Changing Epidemiology: Increasing burden of non-B,non-C liver diseases in Japan  Prof. Junko Tanaka(Hiroshima University Hiroshima Japan) 
±³À°½Ã°£ 09¿ù 07ÀÏ ¸íÁöº´¿ø ³óõȦ 14:00~14:15 Changing Epidemiology: Increasing burden of non-B,non-C liver diseases in USA  Prof. W. Ray Kim(Stanford University Palo Alto USA) 
±³À°½Ã°£ 09¿ù 07ÀÏ ¸íÁöº´¿ø ³óõȦ 14:15~14:30 Comparison of practice guidelines of NAFLD between AASLD 2017, EASL 2016 and Asia-Pacific Working Party 2017; similarities and differences  Prof. Hitoshi Yoshiji(Nara Medical University Nara Japan) 
±³À°½Ã°£ 09¿ù 07ÀÏ ¸íÁöº´¿ø ³óõȦ 14:30~14:45 Characteristics of NASH-associated HCC and its clinical impacts in Korea  Dr. Eun Ju Cho(Seoul National University Seoul Korea) 
±³À°½Ã°£ 09¿ù 07ÀÏ ¸íÁöº´¿ø ³óõȦ 14:45~15:00 Characteristics of NASH-associated HCC and its clinical impacts in Japan  Dr. Soo Ki Kim(Kobe-Asahi Hospital Kobe Japan) 
±³À°½Ã°£ 09¿ù 07ÀÏ ¸íÁöº´¿ø ³óõȦ 15:00~15:15 Characteristics of NASH-associated HCC and its clinical impacts in USA  Prof. W. Ray Kim(Stanford University Palo Alto USA) 
È޽Ġ09¿ù 07ÀÏ ¸íÁöº´¿ø ³óõȦ 15:15~15:30 Coffee Break  () 
±³À°½Ã°£ 09¿ù 07ÀÏ ¸íÁöº´¿ø ³óõȦ 15:30~15:45 Changing epidemiology of acute viral hepatitis: Hepatitis E in Korea  Prof. Sook Hyang Jeong(Seoul National University Bundang Hospital Seongnam Korea) 
±³À°½Ã°£ 09¿ù 07ÀÏ ¸íÁöº´¿ø ³óõȦ 15:45~16:00 Changing epidemiology of acute viral hepatitis: Hepatitis E in Japan  Dr. Jong-Hon Kang(Teine Keijinkai Hospital Sapporo Japan) 
±³À°½Ã°£ 09¿ù 07ÀÏ ¸íÁöº´¿ø ³óõȦ 16:00~16:20 Liver Immunology: Immunotherapy of HCC vs transplantation tolerance - Immunotherapy of HCC with check-point inhibitors  Dr. Su Jong Yu(Seoul National University Seoul Korea) 
±³À°½Ã°£ 09¿ù 07ÀÏ ¸íÁöº´¿ø ³óõȦ 16:20~16:40 Liver Immunology: Immunotherapy of HCC vs transplantation tolerance - Operational transplantation tolerance with Treg cell therapy  Prof. Hideki Ohdan(Hiroshima University Hiroshima Japan) 
±³À°½Ã°£ 09¿ù 07ÀÏ ¸íÁöº´¿ø ³óõȦ 16:40~17:00 Systemic therapy of HCC on the horizon other than check-point inhibitors - Oncolytic virotherapy of HCC: Pros and cons  Prof. Takeshi Yamada(University of Tsukuba Tsukuba Japan) 
±³À°½Ã°£ 09¿ù 07ÀÏ ¸íÁöº´¿ø ³óõȦ 17:00~17:30 Approach to the risk and prevention of HCC in the era of precision medicine - Is the time ripe for application of GWAS in clinical hepatology?  Prof. Naoya Kato(Chiba University Chiba Japan) 
±³À°½Ã°£ 09¿ù 07ÀÏ ¸íÁöº´¿ø ³óõȦ 17:30~17:45 Summary of the 3rd MILS  Prof. W. Ray Kim(Stanford University Palo Alto USA) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ¸íÁöº´¿ø The 3nd MYONGJI INTERNATIONAL LIVER SYMPOSIUM : 2018-09-07""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ¼­¿ï´ëÇб³º´¿ø ¾È°ú ±Ý¿ä¼¼¹Ì³ª : 2018-09-07
´ÙÀ½±Û 2018³âµµ ´ëÇѺñ¸¸ÇÐȸ ±¹Á¦Çмú´ëȸ(ICOMES 2018) - 09/07 : 2018-09-07
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20694 ´ëÀü Á¦8ȸ ³»ºÐºñ ÃÊÀ½ÆÄ ¹× ±â´É°Ë»ç ¿¬¼ö°­Á : 2024-06-29 0 35 2024-05-11
20693 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 4Â÷ : 2024-06-29 0 32 2024-05-11
20692 ¼­¿ï Á¦24ȸ ´ëÇÑÀ¯Àü¼º´ë»çÁúȯÇÐȸ Á¤±âÇмú´ëȸ : 2024-06-28 0 34 2024-05-11
20691 °æ±â Á¤½Å°Ç°­ÀÇÇаú ÀÓ»ó¿¡¼­ À¯¿ëÇÑ Ä¡·á¹ý : 2024-06-26 0 40 2024-05-11
20690 ¼­¿ï (¿Â¶óÀÎ)2024 ÇѾç´ëÇб³º´¿ø È£Èí±â¾Ë·¹¸£±â ¿¬¼ö°­Á : 2024-06-22 0 35 2024-05-11
20689 ºÎ»ê °í½Å´ëÇб³º¹À½º´¿ø Á¦20ȸ °©»ó¼±¿¬¼öȸ : 2024-06-22 0 26 2024-05-11
20688 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 3Â÷ : 2024-06-22 0 8 2024-05-11
20687 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (2ÀÏÂ÷) : 2024-06-22 0 10 2024-05-11
20686 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 2 : 2024-06-21 0 23 2024-05-11
20685 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (1ÀÏÂ÷) : 2024-06-21 0 13 2024-05-11
20684 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 1 : 2024-06-20 0 11 2024-05-11
20683 ¼­¿ï ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ (¿Â¶óÀÎ) ¼­¿ï°æÀÎÁöȸ 277Â÷ ¿ù·ÊÁý´ãȸ : 2024-06-18 0 26 2024-05-11
20682 ¼­¿ï 2024 °­µ¿±¸ÀÇ»çȸ Á¦3Â÷ ¿¬¼ö±³À°(¿°Áõ¼º ÀåÁúȯ,ºñ¸¸ ¾à¹° Ä¡·á ) : 2024-06-17 0 15 2024-05-11
20681 ¼­¿ï ´ëÇÑ´ç´¢º´ÇÐȸ Á¦29Â÷ ´ç´¢º´ ¿¬¼ö°­Á : 2024-06-16 0 25 2024-05-11
20680 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 2Â÷ : 2024-06-15 0 18 2024-05-11
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷